Beaulieu Joseph 4
4 · Epizyme, Inc. · Filed Sep 3, 2020
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Beaulieu Joseph
Corporate Controller
Transactions
- Sale
Common Stock, par value $0.0001
2019-09-03$12.77/sh−971$12,400→ 6,501 total - Sale
Common Stock, par value $0.0001
2020-09-02$12.88/sh−543$6,994→ 5,958 total - Award
Stock Option (Right to Buy)
2020-09-01+6,650→ 6,650 totalExercise: $12.79Exp: 2030-08-31→ Common Stock (6,650 underlying)
Footnotes (4)
- [F1]The reporting person acquired 1,120 and 971 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan on February 28, 2019 and August 31, 2019, respectively, that were not previously reported on Form 4.
- [F2]The reporting person acquired 543 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan on August 31, 2020.
- [F3]Effected pursuant to a trading plan adopted on March 26, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F4]This option was granted on September 1, 2020 pursuant to the Company's 2013 Stock Incentive Plan with respect to 6,650 shares of Common Stock, with 25% vesting on September 1, 2021 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.